Fok, Ezio T. http://orcid.org/0000-0001-7427-8644
Moorlag, Simone J. C. F. M.
Negishi, Yutaka http://orcid.org/0000-0002-5134-3957
Groh, Laszlo A.
dos Santos, Jéssica Cristina
Gräwe, Cathrin http://orcid.org/0000-0002-3010-8990
Monge, Valerie Villacorta
Craenmehr, Daphne D. D.
van Roosmalen, Mellanie
da Cunha Jolvino, David Pablo
Migliorini, Letícia Busato
Neto, Ary Serpa
Severino, Patricia http://orcid.org/0000-0002-6682-9343
Vermeulen, Michiel http://orcid.org/0000-0003-0836-6894
Joosten, Leo A. B. http://orcid.org/0000-0001-6166-9830
Netea, Mihai G. http://orcid.org/0000-0003-2421-6052
Fanucchi, Stephanie
Mhlanga, Musa M. http://orcid.org/0000-0003-1381-3409
Article History
Received: 19 May 2022
Accepted: 26 October 2023
First Online: 13 December 2023
Competing interests
: M.M.M. and S.F. are founders of Lemba Therapeutics. M.G.N. and L.A.B.J. are founders of TTxD. M.M.M., S.F., M.G.N. and L.A.B.J. are equity holders in Lemba Therapeutics. The other authors declare no competing interests.